|
|
News Breaks | | | | November 15, 2012 | | 06:24 EDT |  | ONCS | OncoSec's NeoPulse shows positive Phase IV study results
OncoSec Medical announced positive interim results from a Phase IV trial investigating the use of NeoPulse therapy to treat solid tumors in skin cancer patients. Data from the trial showed a complete response of greater than 90% in basal cell carcinoma patients and 70% in squamous cell carcinoma patients at six months. The treatment was well-tolerated. The most frequent treatment-related adverse events were pain, infection and insomnia; all were transient and manageable. | |
|
News For ONCS From The Last 14 Days Check below for free stories on ONCS the last two weeks. |
|
|
| June 11, 2013 | | 06:10 EDT | | ONCS | OncoSec signs SRA woth Old Dominion University and Frank Reidy Research Center
 Subscribe for More Information | |
|
|
|
|
|
|
